This prospective cross-sectional study examined the effects of major ozone autohemotherapy (MAH) on patients with fibromyalgia syndrome (FMS). The treatment involved 13 sessions of ozonated blood therapy, which resulted in significant improvements in pain reduction, physical functionality, and quality of life as measured by the Fibromyalgia Impact Questionnaire (FIQ) and
